Last updated on April 18, 2014 at 1:21 EDT

Latest MedImmune Ventures Stories

2013-10-16 08:28:45

- Co-investors include Hatteras Venture Partners and Mountain Group Capital CHAPEL HILL, N.C., Oct. 16, 2013 /PRNewswire/ -- G1 Therapeutics, Inc. today announced that it has raised a Series A financing of $12.5M that will enable the advancement of its lead clinical candidate through the filing of an Investigational New Drug application (IND) and initial clinical testing. The financing was led by MedImmune Ventures. Co-investors include Hatteras Venture Partners and Mountain Group...

2010-06-10 07:00:00

GAITHERSBURG, Md., June 10 /PRNewswire/ -- MedImmune announced today that Ron Laufer, M.D., has been appointed Senior Managing Director of MedImmune Ventures, the company's venture capital arm. Laufer's appointment will strengthen MedImmune's long-term commitment to supporting scientific innovation through strategic venture capital investments. "I am pleased to welcome Ron Laufer aboard at MedImmune, and we are honored to have such an experienced, high-caliber individual join our team,"...